enGene (NASDAQ: ENGN) is a late-stage biotechnology company mainstreaming genetic medicines through the delivery of therapeutics to mucosal tissues and other organs, whose lead product candidate, detalimogene voraplasmid, is being evaluated in an ongoing pivotal study for patients with non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (Cis) who are unresponsive to BCG. Detalimogene voraplasmid was developed using enGene’s proprietary Dually Derivatized Oligochitosan (DDX) platform, which enables penetration of mucosal tissues and delivery of a wide range of sizes and types of cargo, including DNA and various forms of RNA. For more information, visit enGene.com. Role
As a Senior Medical Science Liaison, Field Medical Affairs, you will engage in scientific exchange and collaborate with Uro-Oncology disease experts and product information as well as research initiatives. We provide scientific and/or medical expertise by thoroughly understanding Uro Oncology as a therapeutic area serving as a scientific/medical resource. We present scientific and clinical data and disease state awareness in response to requests for information to therapeutic area specialists, practitioners, investigators, research coordinators, site personnel and internal partners.
Preference for candidates located on the East (EST)
enGene USA Inc. is an Equal Opportunity Employer:
All applicants will be considered for employment without attention to race, color, religion, sex, sexual orientation, gender identity, national origin, veteran, or disability status. At enGene USA Inc., we are building a community of intelligent and passionate team members that share our Vision, Mission, and Values, and while the biotechnology space can feel limited in BIPOC, non-binary and even female representation, we endeavor to make hiring decisions that will continue to grow and support our team in the direction of maintaining cultural diversity and sustainability.